1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. INTELLIA THERAPEUTICS INC

Intellia Therapeutics Inc

XNAS: NTLA

Weak Stock
Download real time

9.00 0.30 (3.45%)

68.12% Fall from 52W High

3.7M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
12S
18W
0O
2T
931.7

Market Cap

Below industry Median
-1.8

PE TTM

Negative PE TTM
0.2

PEG TTM

PEG TTM is less than 1
1.1

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility

Intellia Therapeutics Inc - NTLA - stock price prediction, stock price target, analyst ratings from 29 analysts

Intellia Therapeutics Inc has a share price target of US$ 44, revenue growth forecast of -17.9%, and profit growth estimate of 6.8% for FY25, based on top 29 analyst calls.

Forecaster Screeners